Form 4: Lemaitre Vascular Inc. Executive Trent G. Kamke Reports Acquisition of Dividend Equivalent Rights

Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Summary

• On March 28, 2024, Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., acquired dividend equivalent rights.
• These rights are associated with restricted stock unit (RSU) and performance share unit (PSU) awards previously granted to Kamke.
• The dividend equivalent rights vest proportionately with the underlying RSU and PSU awards.
• Each dividend equivalent right represents the economic equivalent of one share of Lemaitre Vascular's common stock.
• The acquired dividend equivalent rights are linked to awards granted on various dates: December 20, 2019 (0.41 rights), December 2, 2020 (0.7664 rights), December 11, 2021 (1.4234 rights), December 12, 2022 (2.1771 rights for RSU and 2.1771 rights for PSU), and December 8, 2023 (2.4812 rights).
• Following the transaction, Kamke directly owns 9.0511, 12.1499, 15.3503, 11.2107, 11.2023, and 2.4812 dividend equivalent rights respectively for each grant.

Sentiment

Score: 7

Explanation: The document reflects a neutral sentiment. It's a standard regulatory filing related to executive compensation, indicating alignment of interests but not necessarily a positive or negative outlook for the company's performance.

Positives

• The acquisition of dividend equivalent rights suggests continued alignment of the executive's interests with those of the shareholders.
• The vesting schedule ties the value of these rights to the long-term performance of the company.

Industry Context

Executive compensation practices, including the use of restricted stock units and dividend equivalent rights, are common in the medical device industry to incentivize and retain key personnel.

Comparison to Industry Standards

• Companies like Medtronic, Boston Scientific, and Abbott also utilize equity-based compensation, including RSUs and PSUs, to align executive interests with shareholder value.
• Dividend equivalent rights are a fairly standard feature of RSU grants, ensuring that executives receive the same dividend benefits as common shareholders during the vesting period.

Stakeholder Impact

• Shareholders may view the granting and vesting of dividend equivalent rights as a positive sign, indicating that management's interests are aligned with theirs.
• Employees may see this as a standard part of the company's compensation package.

Key Dates